Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation

PLoS Pathogens

Volumn 8, Issue 6, 2012, Pages

  Iwashkiw, Jeremy A ^a   Seper, Andrea ^b   Weber, Brent S ^a   Scott, Nichollas E ^a,c   Vinogradov, Evgeny ^d   Stratilo, Chad ^e   Reiz, Bela ^a   Cordwell, Stuart J ^c   Whittal, Randy ^a   Schild, Stefan ^b   Feldman, Mario F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF SYDNEY   (Australia)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^e DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE; GLUCOSE; GLUCURONIC ACID; GLYCAN; GLYCOPROTEIN; N ACETYLGLUCOSAMINE; PENTASACCHARIDE; BACTERIAL PROTEIN; MEMBRANE PROTEIN; POLYSACCHARIDE;

ACINETOBACTER BAUMANNII; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOFILM; CARBON NUCLEAR MAGNETIC RESONANCE; CHROMATOGRAPHY; CONTROLLED STUDY; DICTYOSTELIUM DISCOIDEUM; GALLERIA MELLONELLA; GENE SEQUENCE; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HOMOLOGOUS RECOMBINATION; HOSPITAL INFECTION; IN VIVO STUDY; INSECT; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PROTEIN GLYCOSYLATION; PROTON NUCLEAR MAGNETIC RESONANCE; SEPSIS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; ZWITTERIONIC HYDROPHILIC INTERACTION CHROMATOGRAPHY; ACINETOBACTER INFECTION; ANIMAL; BAGG ALBINO MOUSE; CONFOCAL MICROSCOPY; GENE INACTIVATION; GLYCOSYLATION; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENICITY; VIRULENCE; WESTERN BLOTTING;

ACINETOBACTER BAUMANNII; DICTYOSTELIUM DISCOIDEUM; GALLERIA MELLONELLA; HEXAPODA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; BACTERIAL PROTEINS; BIOFILMS; BLOTTING, WESTERN; GENE KNOCKOUT TECHNIQUES; GLYCOPROTEINS; GLYCOSYLATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; POLYSACCHARIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VIRULENCE;

EID: 84864072948     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002758     Document Type: Article

References (71)

1. Towner KJ, (2009) Acinetobacter: an old friend, but a new enemy. J Hosp Infect 73: 355 363.
2. Peleg AY, Seifert H, Paterson DL, (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538 582.
3. Rello J, Diaz E, (2003) Acinetobacter baumannii: a threat for the ICU? Intensive Care Med 29: 350 351.
4. Hanlon GW, (2005) The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting. Lett Appl Microbiol 41: 375 378.
5. Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, (2007) New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 21: 601 614.
6. Fournier PE, Richet H, (2006) The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 42: 692 699.
7. Giamarellou H, Antoniadou A, Kanellakopoulou K, (2008) Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents 32: 106 119.
8. Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, (2010) Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis 50: 1611 1616.
9. Arroyo LA, Mateos I, Gonzalez V, Aznar J, (2009) In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group. Antimicrob Agents Chemother 53: 1295 1296.
10. Choi CH, Hyun SH, Lee JY, Lee JS, Lee YS, (2008) Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity. Cell Microbiol 10: 309 319.
11. Tomaras AP, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA, (2008) Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology 154: 3398 3409.
12. Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litran T, (2009) The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol 191: 5953 5963.
13. Gordon NC, Wareham DW, (2010) Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 35: 219 226.
14. Gonzalez RH, Nusblat A, Nudel BC, (2001) Detection and characterization of quorum sensing signal molecules in Acinetobacter strains. Microbiol Res 155: 271 277.
15. Nothaft H, Szymanski CM, (2010) Protein glycosylation in bacteria: sweeter than ever. Nat Rev Microbiol 8: 765 778.
16. Vik A, Aas FE, Anonsen JH, Bilsborough S, Schneider A, (2009) Broad spectrum O-linked protein glycosylation in the human pathogen Neisseria gonorrhoeae. Proc Natl Acad Sci U S A 106: 4447 4452.
17. Fletcher CM, Coyne MJ, Villa OF, Chatzidaki-Livanis M, Comstock LE, (2009) A general O-glycosylation system important to the physiology of a major human intestinal symbiont. Cell 137: 321 331.
18. Alaimo C, Catrein I, Morf L, Marolda CL, Callewaert N, (2006) Two distinct but interchangeable mechanisms for flipping of lipid-linked oligosaccharides. Embo J 25: 967 976.
19. Faridmoayer A, Fentabil MA, Mills DC, Klassen JS, Feldman MF, (2007) Functional characterization of bacterial oligosaccharyltransferases involved in O-linked protein glycosylation. J Bacteriol 189: 8088 8098.
20. Scott NE, Parker BL, Connolly AM, Paulech J, Edwards AV, (2011) Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation MS applied to the N-linked glycoproteome of Campylobacter jejuni. Mol Cell Proteomics 10: M000031 MCP000201.
21. Power PM, Seib KL, Jennings MP, (2006) Pilin glycosylation in Neisseria meningitidis occurs by a similar pathway to wzy-dependent O-antigen biosynthesis in Escherichia coli. Biochem Biophys Res Commun 347: 904 908.
22. Gebhart C, Ielmini MV, Reiz B, Price NL, Aas FE, (2012) Characterization of exogenous bacterial oligosaccharyltransferases in Escherichia coli reveals the potential for O-linked protein glycosylation in Vibrio cholerae and Burkholderia thailandensis. Glycobiology. In press.
23. Hug I, Feldman MF, (2011) Analogies and homologies in lipopolysaccharide and glycoprotein biosynthesis in bacteria. Glycobiology 21: 138 151.
24. Dehal PS, Joachimiak MP, Price MN, Bates JT, Baumohl JK, (2010) MicrobesOnline: an integrated portal for comparative and functional genomics. Nucleic Acids Res 38: D396 400.
25. Pantophlet R, Brade L, Dijkshoorn L, Brade H, (1998) Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter. J Clin Microbiol 36: 1245 1250.
26. Cabral MP, Soares NC, Aranda J, Parreira JR, Rumbo C, (2011) Proteomic and Functional Analyses Reveal a Unique Lifestyle for Acinetobacter baumannii Biofilms and a Key Role for Histidine Metabolism. J Proteome Res 10: 3399 3417.
27. Pessione E, Pessione A, Lamberti C, Coisson DJ, Riedel K, (2009) First evidence of a membrane-bound, tyramine and beta-phenylethylamine producing, tyrosine decarboxylase in Enterococcus faecalis: a two-dimensional electrophoresis proteomic study. Proteomics 9: 2695 2710.
28. Gaddy JA, Actis LA, (2009) Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 4: 273 278.
29. Gaddy JA, Arivett BA, McConnell MJ, Lopez-Rojas R, Pachon J, (2012) Role of Acinetobactin-Mediated Iron Acquisition Functions in the Interaction of Acinetobacter baumannii Strain ATCC 19606T with Human Lung Epithelial Cells, Galleria mellonella Caterpillars, and Mice. Infect Immun 80: 1015 1024.
30. Wand M, Bock LJ, Turton JF, Nugent PG, Sutton JM, (2011) Virulence of strains of Acinetobacter baumannii is enhanced in Galleria mellonella following biofilm adaptation. J Med Microbiol 61: 470 7.
31. Antunes LC, Imperi F, Carattoli A, Visca P, (2011) Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One 6: e22674.
32. Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC Jr, (2009) Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 53: 2605 2609.
33. Hornsey M, Wareham DW, (2011) In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob Agents Chemother 55: 3534 3537.
34. Hasselbring BM, Patel MK, Schell MA, (2011) Dictyostelium discoideum as a model system for identification of Burkholderia pseudomallei virulence factors. Infect Immun 79: 2079 2088.
35. Jander G, Rahme LG, Ausubel FM, (2000) Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol 182: 3843 3845.
36. Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, (2005) Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 73: 3842 3850.
37. Lopez-Rojas R, Dominguez-Herrera J, McConnell MJ, Docobo-Perez F, Smani Y, (2010) Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis 203: 545 548.
38. Smani Y, Lopez-Rojas R, Dominguez-Herrera J, Docobo-Perez F, Marti S, (2011) In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii. Clin Microbiol Infect 18: E1 4.
39. Lau GW, Ran H, Kong F, Hassett DJ, Mavrodi D, (2004) Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun 72: 4275 4278.
40. Snitkin ES, Zelazny AM, Montero CI, Stock F, Mijares L, (2011) Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc Natl Acad Sci U S A 108: 13758 63.
41. Szymanski CM, Burr DH, Guerry P, (2002) Campylobacter protein glycosylation affects host cell interactions. Infect Immun 70: 2242 2244.
42. Borud B, Aas FE, Vik A, Winther-Larsen HC, Egge-Jacobsen W, (2011) Genetic, structural, and antigenic analyses of glycan diversity in the O-linked protein glycosylation systems of human Neisseria species. J Bacteriol 192: 2816 2829.
43. Jennings MP, Jen FE, Roddam LF, Apicella MA, Edwards JL, (2011) Neisseria gonorrhoeae pilin glycan contributes to CR3 activation during challenge of primary cervical epithelial cells. Cell Microbiol 13: 885 896.
44. Fletcher CM, Coyne MJ, Comstock LE, (2011) Theoretical and experimental characterization of the scope of protein O-glycosylation in Bacteroides fragilis. J Biol Chem 286: 3219 3226.
45. Knirel YA, Kochetkov NK, (1994) [Structure of lipopolysaccharides from gram-negative bacteria. III. Structure of O-specific polysaccharides]. Biokhimiia 59: 1784 1851.
46. Parsons LM, Lin F, Orban J, (2006) Peptidoglycan recognition by Pal, an outer membrane lipoprotein. Biochemistry 45: 2122 2128.
47. Johnson LR, (2008) Microcolony and biofilm formation as a survival strategy for bacteria. J Theor Biol 251: 24 34.
48. Bazaka K, Crawford RJ, Nazarenko EL, Ivanova EP, (2011) Bacterial extracellular polysaccharides. Adv Exp Med Biol 715: 213 226.
49. Hoiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, (2011) The clinical impact of bacterial biofilms. Int J Oral Sci 3: 55 65.
50. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG, (2002) Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 184: 1140 1154.
51. O'Toole GA, Kolter R, (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30: 295 304.
52. Cosson P, Soldati T, (2008) Eat, kill or die: when amoeba meets bacteria. Curr Opin Microbiol 11: 271 276.
53. Bozue JA, Johnson W, (1996) Interaction of Legionella pneumophila with Acanthamoeba castellanii: uptake by coiling phagocytosis and inhibition of phagosome-lysosome fusion. Infect Immun 64: 668 673.
54. Kavanagh K, Reeves EP, (2004) Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol Rev 28: 101 112.
55. Ugalde JE, Czibener C, Feldman MF, Ugalde RA, (2000) Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication. Infect Immun 68: 5716 5723.
56. Cagatay TI, Hickford JG, (2008) Glycosylation of type-IV fimbriae of Dichelobacter nodosus. Vet Microbiol 126: 160 167.
57. Marolda CL, Lahiry P, Vines E, Saldias S, Valvano MA, (2006) Micromethods for the characterization of lipid A-core and O-antigen lipopolysaccharide. Methods Mol Biol 347: 237 252.
58. Good DM, Wenger CD, Coon JJ, (2010) The effect of interfering ions on search algorithm performance for electron-transfer dissociation data. Proteomics 10: 164 167.
59. Good DM, Wenger CD, McAlister GC, Bai DL, Hunt DF, (2009) Post-acquisition ETD spectral processing for increased peptide identifications. J Am Soc Mass Spectrom 20: 1435 1440.
60. Seper A, Fengler VH, Roier S, Wolinski H, Kohlwein SD, (2011) Extracellular nucleases and extracellular DNA play important roles in Vibrio cholerae biofilm formation. Mol Microbiol 82: 1015 1037.
61. Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, (2000) Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146 (Pt 10): 2395 2407.
62. Pukatzki S, Kessin RH, Mekalanos JJ, (2002) The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum. Proc Natl Acad Sci U S A 99: 3159 3164.
63. Ko WC, Lee HC, Chiang SR, Yan JJ, Wu JJ, (2004) In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain. J Antimicrob Chemother 53: 393 395.
64. Fattahian Y, Rasooli I, Mousavi Gargari SL, Rahbar MR, Darvish Alipour Astaneh S, (2011) Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Microb Pathog 51: 402 406.
65. McConnell MJ, Dominguez-Herrera J, Smani Y, Lopez-Rojas R, Docobo-Perez F, (2011) Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii. Infect Immun 79: 518 526.
66. Batson HC, Landy M, Brown M, (1950) The virulence and immunogenicity of strains derived from Salmonella typhosa 58 (Panama carrier). J Exp Med 91: 231 243.
67. McConnell MJ, Pachon J, (2010) Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. Vaccine 29: 1 5.
68. Piechaud M, Second L, (1951) [Studies of 26 strains of Moraxella Iwoffi]. Ann Inst Pasteur (Paris) 80: 97 99.
69. Dykxhoorn DM, St Pierre R, Linn T, (1996) A set of compatible tac promoter expression vectors. Gene 177: 133 136.
70. Hunger M, Schmucker R, Kishan V, Hillen W, (1990) Analysis and nucleotide sequence of an origin of DNA replication in Acinetobacter calcoaceticus and its use for Escherichia coli shuttle plasmids. Gene 87: 45 51.
71. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP, (1998) A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212: 77 86.